Value-based healthcare in Europe: Laying the foundation
This Economist Intelligence Unit (EIU) report, commissioned by Gilead Sciences, explores important questions about healthcare systems in Europe.

29 Feb 2016

Value-based healthcare looks at health outcomes of treatment relative to cost. In this particular report The EIU examines the way in which value is interpreted across the continent, the extent to which European countries are adopting cost-effectiveness as a key criterion for assessing it, and the efforts to develop new models for pricing innovation.
Further reading:

Value-based healthcare in the UK: A system of trial and error
This Economist Intelligence Unit (EIU) report, commissioned by Gilead Sciences, explores important questions about the UK healthcare system.

Value-based healthcare in Portugal: Necessity is the mother of invention
This paper examines how the recent economic crisis has shaped health technology assessment; the role of the hospital sector; and promising initiatives in integrated care, family health units and a new process for the re-evaluation of health technologies.

Value-based healthcare in France: A slow adoption of cost-effectiveness criteria
This new Economist Intelligence Unit (EIU) report, commissioned by Gilead Sciences, explores important questions about the French healthcare system. How is healthcare innovation assessed in France? To what extent is value for money influencing price neg

Value-based healthcare in Spain: Regional experimentation in a shared governance setting
Value-based healthcare in Spain is an Economist Intelligence Unit (EIU) report, commissioned by Gilead Sciences. It looks at health outcomes of treatment relative to cost and at the structure of Spanish healthcare delivery.